Frankfurt - Delayed Quote EUR
Vertex Pharmaceuticals Incorporated (VX1.F)
388.15
-0.80
(-0.21%)
As of 8:02:48 AM GMT+2. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 27 | 26 | 32 | 30 |
| Avg. Estimate | 2.91B | 3.04B | 11.94B | 13.23B |
| Low Estimate | 2.8B | 2.98B | 11.75B | 11.94B |
| High Estimate | 3.01B | 3.13B | 12.25B | 14.95B |
| Year Ago Sales | 2.65B | 2.77B | 11.02B | 11.94B |
| Sales Growth (year/est) | 9.90% | 9.85% | 8.32% | 10.83% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VX1.F | -- | -- | -- | -- |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.96% |
Upgrades & Downgrades
| Maintains | RBC Capital: Sector Perform to Sector Perform | 5/6/2025 |
| Maintains | Scotiabank: Sector Perform to Sector Perform | 5/6/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 5/6/2025 |
| Maintains | JP Morgan: Overweight to Overweight | 5/6/2025 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 5/6/2025 |
| Reiterates | Needham: Hold to Hold | 5/6/2025 |